Cancer International Research Group Inc is categorized under Medical Research in Los Angeles, CA and active since 2001.
Cancer International Research Group Inc was established in 2001, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Dennis Sleman at the company’s single location by writing to 11111 Santa Monica Boulevard, Los Angeles, California CA 90025 or by phoning (310) 235-3445. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer International Research Group Inc |
| Contact Person: | Dennis Sleman |
| Address: | 11111 Santa Monica Boulevard, Los Angeles, California 90025 |
| Phone Number: | (310) 235-3445 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Cancer International Research Group Inc was started in 2001 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Dennis Sleman for inquiries that concern Cancer International Research Group Inc by calling the company number (310) 235-3445, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer International Research Group Inc can be found at the coordinates as well as the street address 11111 Santa Monica Boulevard in Los Angeles, California 90025.
For its online presence, you may visit Cancer International Research Group Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.